These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 11000008)
21. Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion. Warżajtis B; Glišić BĐ; Savić ND; Pavic A; Vojnovic S; Veselinović A; Nikodinovic-Runic J; Rychlewska U; Djuran MI Dalton Trans; 2017 Feb; 46(8):2594-2608. PubMed ID: 28155927 [TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole. Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072 [TBL] [Abstract][Full Text] [Related]
23. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity. Lee PK; Law WH; Liu HW; Lo KK Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537 [TBL] [Abstract][Full Text] [Related]
24. Solution chemistry and cytotoxic properties of novel organogold(III) compounds. Messori L; Marcon G; Cinellu MA; Coronnello M; Mini E; Gabbiani C; Orioli P Bioorg Med Chem; 2004 Dec; 12(23):6039-43. PubMed ID: 15519149 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, spectroscopic characterization, electrochemical behavior and computational analysis of mixed diamine ligand gold(III) complexes: antiproliferative and in vitro cytotoxic evaluations against human cancer cell lines. Al-Jaroudi SS; Monim-ul-Mehboob M; Altaf M; Al-Saadi AA; Wazeer MI; Altuwaijri S; Isab AA Biometals; 2014 Dec; 27(6):1115-36. PubMed ID: 25034122 [TBL] [Abstract][Full Text] [Related]
26. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, characterization and anticancer activity of gold(I) complexes that contain tri-tert-butylphosphine and dialkyl dithiocarbamate ligands. Altaf M; Monim-ul-Mehboob M; Seliman AA; Sohail M; Wazeer MI; Isab AA; Li L; Dhuna V; Bhatia G; Dhuna K Eur J Med Chem; 2015 May; 95():464-72. PubMed ID: 25841201 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems? Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390 [TBL] [Abstract][Full Text] [Related]
29. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin. Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands. Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197 [TBL] [Abstract][Full Text] [Related]
31. Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential. Jakupec MA; Reisner E; Eichinger A; Pongratz M; Arion VB; Galanski MS; Hartinger CG; Keppler BK J Med Chem; 2005 Apr; 48(8):2831-7. PubMed ID: 15828821 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives. Trávnícek Z; Szucová L; Popa I J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304 [TBL] [Abstract][Full Text] [Related]
33. Ethylenediamine-palladium(II) complexes with pyridine and its derivatives: synthesis, molecular structure and initial antitumor studies. Zhao G; Lin H; Yu P; Sun H; Zhu S; Su X; Chen Y J Inorg Biochem; 1999 Mar; 73(3):145-9. PubMed ID: 10331244 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand. Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903 [TBL] [Abstract][Full Text] [Related]
36. Bioconjugation of Cyclometalated Gold(III) Lipoic Acid Fragments to Linear and Cyclic Breast Cancer Targeting Peptides. Śmiłowicz D; Slootweg JC; Metzler-Nolte N Mol Pharm; 2019 Nov; 16(11):4572-4581. PubMed ID: 31596097 [TBL] [Abstract][Full Text] [Related]
37. Complexes of dichloro[2-(dimethylaminomethyl)phenyl-C1,N]gold(III), [Au(damp-C1,N)Cl2], with formylferrocene thiosemicarbazones: synthesis, structure and cytotoxicity. Casas JS; Castaño MV; Cifuentes MC; García-Monteagudo JC; Sánchez A; Sordo J; Abram U J Inorg Biochem; 2004 Jun; 98(6):1009-16. PubMed ID: 15149809 [TBL] [Abstract][Full Text] [Related]
39. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation. Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477 [TBL] [Abstract][Full Text] [Related]
40. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]